Clinical Trial Update: A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Argatroban intravenous versus Desirudin subcutaneous in suspected heparin-induced thrombocytopenia; the study was terminated an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia

Drugs mentioned

• Argatroban (argatroban)
• Desirudin (desirudin)

Snippet

Sponsor: Canyon Pharmaceuticals, Inc. | Conditions: Suspected Heparin-Induced Thrombocytopenia | Phase 4 | Status: TERMINATED | Results posted: 2012-12-31